Umeclidinium Side Effects
Medically reviewed by Drugs.com. Last updated on Dec 12, 2024.
Applies to umeclidinium: inhalation powder.
Serious side effects of umeclidinium
Along with its needed effects, umeclidinium may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking umeclidinium:
Less common side effects
- bladder pain
- bloody or cloudy urine
- body aches or pain
- chest pain
- chills
- cough
- difficult, burning, or painful urination
- difficulty with breathing
- dryness or soreness of the throat
- ear congestion
- fast, pounding, or irregular heartbeat or pulse
- fever
- frequent urge to urinate
- hoarseness
- loss of voice
- lower back or side pain
- sneezing
- sore throat
- tender, swollen glands in the neck
- tightness in the chest
- trouble in swallowing
- unusual tiredness or weakness
- voice changes
Rare side effects
- dizziness
- fainting
Incidence not known
- blindness
- blurred vision
- decreased urination
- difficulty in passing urine (dribbling)
- eye pain or discomfort
- hives, itching, skin rash
- hoarseness
- irritation
- joint pain, stiffness, or swelling
- large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals
- nausea
- redness of the skin
- swelling of the eyelids, face, lips, hands, or feet
- tearing
- tightness in the chest
- troubled swallowing
- vomiting
Other side effects of umeclidinium
Some side effects of umeclidinium may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common side effects
- back, neck, arm, or leg pain
- belching
- bruise
- depression
- diarrhea
- difficulty in moving
- dizziness or lightheadedness
- feeling of constant movement of self or surroundings
- heartburn
- indigestion
- muscle cramps or stiffness
- sensation of spinning
- stomach discomfort, upset, or pain toothache
- upper abdominal or stomach pain
For healthcare professionals
Applies to umeclidinium: inhalation powder.
Cardiovascular adverse events
- Common (1% to 10%): Tachycardia, hypertension, sinus tachycardia (greater than or equal to 1%)
- Uncommon (0.1% to 1%): Atrial fibrillation, idioventricular rhythm, supraventricular tachycardia, supraventricular extrasystoles[Ref]
Dermatologic
- Common (1% to 10%): Rash[Ref]
Gastrointestinal
- Common (1% to 10%): Upper abdominal pain, toothache, dyspepsia (greater or equal to 1%), diarrhea (greater or equal to 1%), nausea (greater or equal to 1%)
- Uncommon (0.1% to 1%): Constipation, dry mouth[Ref]
Genitourinary
- Common (1% to 10%): Urinary tract infection
- Frequency not reported: Worsening of urinary retention[Ref]
Musculoskeletal
- Common (1% to 10%): Arthralgia, myalgia, back pain, neck pain (greater or equal to 1%), pain in extremity (greater or equal to 1%)[Ref]
Nervous system
- Common (1% to 10%): Headache, sinus headache (greater or equal to 1%), dizziness (greater or equal to 1%)
- Uncommon (0.1% to 1%): Dysgeusia[Ref]
Other
Psychiatric
- Common (1% to 10%): Depression (greater or equal to 1%)[Ref]
Respiratory
- Common (1% to 10%): Nasopharyngitis, upper respiratory tract infection, viral respiratory tract infection, cough, sinusitis, pneumonia (greater than or equal to 1%), lower respiratory tract infection (greater than or equal to 1%), rhinitis (greater than or equal to 1%), oropharyngeal pain (greater than or equal to 1%)
- Uncommon (0.1% to 1%): Pharyngitis[Ref]
Ocular
- Frequency not reported: Worsening of narrow-angle glaucoma (eye pain or discomfort, blurred vision, visual halos or colored images in association with red eyes from conjunctival congestion and corneal edema)[Ref]
References
1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
2. Cerner Multum, Inc. "Australian Product Information."
3. (2014) "Product Information. Incruse Ellipta (umeclidinium)." GlaxoSmithKline
More about umeclidinium
- Check interactions
- Compare alternatives
- Reviews (38)
- Dosage information
- During pregnancy
- Drug class: anticholinergic bronchodilators
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Umeclidinium side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.